Back to search

McMaster University

Beta-Glucan Microparticles and Nanoparticles as Drug Delivery Vehicles and Macrophage Immunomodulators for the Treatment of Fibrotic Diseases and Cancer

Abstract

dc:description.abstract

Macrophages are cells of the innate immune system that play key roles in maintaining homeostasis via inflammation, immune surveillance, and tissue remodelling. However, macrophages are highly plastic cells that can change phenotype in response to endogenous and exogenous stimuli; moreover, the aberrant activation of these cells can lead to the pathogenesis and progression of several diseases including cancer and fibrotic disease. Significant effort has thus been made to develop therapies that target macrophages and control their behaviour at the disease site. While several small molecule therapeutics have been developed to modulate macrophage behaviour, the development of inherently immunomodulatory micro- and nanomaterials offers additional potential to not only facilitate drug delivery but also directly induce immunomodulatory effects on disease-progressing cells. One such material is yeast beta-glucan (YBG), a yeast-derived polysaccharide with established capacity to reprogram macrophages from a more pro-fibrotic state to a more pro-inflammatory state. While YBG’s biological properties show promise in treating macrophage-driven diseases tied to fibrotic responses, its physicochemical properties such as low solubility and microparticulate nature significantly hamper its development as an immunomodulatory therapeutic. In this thesis, micro- and nanoparticle systems derived from yeast beta-glucan (YBG) were developed as drug delivery vehicles, standalone immunomodulators, or combinations thereof. The first half of this thesis discusses the preparation of highly respirable YBG microparticles for direct pulmonary delivery for treatment of fibrotic lung disease using supercritical fluids to both process native YBG and to introduce micro/nano porosity. Extensive in vitro and ex vivo characterization highlighted YBG’s ability to modulate macrophages toward an anti-fibrotic phenotype, while aerodynamic testing confirmed high respirability to facilitate direct access to the diseased lung tissue. The second half of the thesis describes the preparation of nanoscale YBG systems by solubilizing YBG into sulfated oligomers and then assembling it into nanoparticles by hydrophobic grafting/self-assembly or electrostatic nanocomplexation. Nanoparticle properties were optimized for size, stability, and drug loading capabilities, with the ability to deliver high doses of chemotherapeutics and effectively kill cancer cells demonstrated both in 2D and 3D in vitro models. The innate immunomodulatory properties of native YBG were preserved in some nanoparticle formulations, facilitating additional capacity to modulate macrophage behaviour without inducing cytotoxicity. Overall, this thesis provides new approaches to rationally design YBG micro- and nanoparticles for therapeutic applications, offering a promising avenue to improve the clinical translation of YBG as both a standalone immunotherapeutic and a dual chemo/immunotherapeutic.

Degree

thesis:*
Department dc:contributor.department
Chemical Engineering
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Dowdall, Nate James
Advisor dc:contributor.advisor
  • Hoare, Todd

Subjects

dc:subject × 7

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
McMaster University
Base URL
macsphere.mcmaster.ca/server/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Dowdall, Nate James. Beta-Glucan Microparticles and Nanoparticles as Drug Delivery Vehicles and Macrophage Immunomodulators for the Treatment of Fibrotic Diseases and Cancer. 2026. https://hdl.handle.net/11375/33363